Member Benefits

Request for Applications: Native-Serving Organization to Identify Legal/Practical Strategies to Promote Public Health Data Sharing

The National Association of County and City Health Officials (NACCHO) is seeking a native serving organization to develop a working advisory committee of tribal members with broad representation, tribal experts, public health practitioners serving tribes, and other native serving partners to identify legal and practical strategies that have proven to be successful in supporting, facilitating, and enhancing public health focused data sharing, including data collected by health departments as part of their programmatic functions such as surveillance data as well as administrative data that provides insight into the needs of tribes and urban communities.

The CDC-OTASA and CDC-PHLP have entered into a cooperative agreement with NACCHO to award up to $200,000 in funding to a native-serving organization to build upon the data sharing successes that some tribal nations and urban Indian communities have demonstrated to improve public health outcomes and to further build upon the knowledge and expertise of an advisory committee to develop culturally supportive strategies for effective data sharing agreements, training, and dialogue. The identified organization may work with other entities to complete project work. However, NACCHO will only contract with, and provide funding to, one organization. Project period is from the date of the executed contract to July 31, 2020.

The deadline for submission is 5 pm ET on Friday, April 24, 2020. NACCHO will not accept applications received after the deadline. Decisions will be made, and applicants will be notified of their selection status, no later than May 8, 2020. Applicants may pose individual questions to NACCHO or submit an application by e-mailing Geoff Mwaungulu Jr. at gmwaungulu@naccho.org.

The Bureau of Justice Assistance’s (BJA) Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) is seeking applications to develop, implement, or expand comprehensive programs in response to illicit opioids, stimulants, or other substances of abuse. Awards will be made in two categories for the following amounts:

Category 1: Local or Tribal Applications

• Subcategory 1a – An urban area or large county with a population greater than 500,000: up to $1,200,000
• Subcategory 1b – A suburban area or medium-size county with a population between 100,000 and 500,000: up to $900,000
• Subcategory 1c – A rural area or small county (as defined in the eligibility section) with a population of fewer than 100,000 or a federally recognized Indian tribe: up to $600,000

Category 2: State Applications

• Applications from states on behalf of county, local, municipal, or tribal communities: up to $6,000,000

All applications are due May 21, 2020 by 11:59 PM ET. Visit https://bja.ojp.gov/funding/opportunities/bja-2020-17023 for solicitation information, eligibility details, and application guidelines.

The Centers for Disease Control and Prevention released a new notice of funding opportunity (NOFO), Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (CDC-RFA-PS20-2009). The NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C.

Applicants should develop a jurisdictional viral hepatitis elimination plan, promote comprehensive hepatitis B and C reporting, improve HBV and HCV testing policies, and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics); and increased access to services preventing viral hepatitis and other bloodborne infections among persons who inject drugs (PWID).

Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of hepatitis B, C and HIV among PWID in jurisdictions disproportionately affected by high-risk drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. Applications are due May 18, 2020 by 11:59 PM ET. For more information, visit here.